I am an experienced pharmaceutical physician with over 20 years of international experience with a focus on oncology drug development, translational medicine, and early phase clinical trials. Currently, I serve as Vice President of Clinical Development at Myricx, where I lead efforts to advance novel antibody drug conjugates toward first-in-human studies.Before joining Myricx, I held the role of Senior Director and Global Clinical Lead at Daiichi Sankyo. In this capacity, I spearheaded early phase clinical trials of antibody drug conjugates across multiple solid tumor types.Earlier in my career, I worked as a Clinical Research Physician at Cancer Research UK’s Centre for Drug Development. I collaborated on a wide range of oncology programs including small molecules, biologics, cell therapies and cancer vaccines. I led Phase 1 trials for both solid and hematological malignancies, gaining diverse expertise in translating various cancer drugs and technologies from preclinical to early clinical development.